Search research articles
Contact Us
Filters
Showing results (91-100 of 100) with videos related to
Page
of 10
Sort By:
You have reached the last page of results.
This site can display upto 100 results.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
August 28, 2014
R47H TREM2 variant increases risk of typical early-onset Alzheimer's disease but not of prion or frontotemporal dementia
Catherine F Slattery, Jonathan A Beck, Lorna Harper, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
August 6, 2021
Comparison of clinical rating scales in genetic frontotemporal dementia within the GENFI cohort
Georgia Peakman, Lucy L Russell, Rhian S Convery, et al.
Annals of Clinical and Translational Neurology
|
September 26, 2018
Presymptomatic white matter integrity loss in familial frontotemporal dementia in the GENFI cohort: A cross-sectional diffusion tensor imaging study
Lize C Jiskoot, Martina Bocchetta, Jennifer M Nicholas, et al.
BMC Neurology
|
January 23, 2024
Updating the study protocol: Insight 46 - a longitudinal neuroscience sub-study of the MRC National Survey of Health and Development - phases 2 and 3
Heidi Murray-Smith, Suzie Barker, Frederik Barkhof, et al.
Brain Communications
|
March 27, 2023
Structural MRI predicts clinical progression in presymptomatic genetic frontotemporal dementia: findings from the GENetic Frontotemporal dementia Initiative cohort
Martina Bocchetta, Emily G Todd, Arabella Bouzigues, et al.
Lancet (London, England)
|
September 11, 2019
Effect of remote ischaemic conditioning on clinical outcomes in patients with acute myocardial infarction (CONDI-2/ERIC-PPCI): a single-blind randomised controlled trial
Derek J Hausenloy, Rajesh K Kharbanda, Ulla Kristine Møller, et al.
Lancet (London, England)
|
October 4, 2025
Effect of repurposed simvastatin on disability progression in secondary progressive multiple sclerosis (MS-STAT2): a phase 3, randomised, double-blind, placebo-controlled trial
Jeremy Chataway, Thomas Williams, James Blackstone, et al.
BMJ Open
|
September 16, 2024
Evaluating the effectiveness of simvastatin in slowing the progression of disability in secondary progressive multiple sclerosis (MS-STAT2): protocol for a multicentre, randomised controlled, double-blind, phase 3 clinical trial in the UK
James Blackstone, Thomas Williams, Jennifer M Nicholas, et al.
Health Technology Assessment (Winchester, England)
|
June 29, 2026
Evaluating the effectiveness of simvastatin in slowing the progression of disability in secondary progressive multiple sclerosis: a synopsis of MS-STAT2, a multicentre, randomised controlled, double-blind, phase 3 clinical trial
Thomas Williams, James Blackstone, Nevin John, et al.
The Lancet. Neurology
|
February 10, 2015
Presymptomatic cognitive and neuroanatomical changes in genetic frontotemporal dementia in the Genetic Frontotemporal dementia Initiative (GENFI) study: a cross-sectional analysis
Jonathan D Rohrer, Jennifer M Nicholas, David M Cash, et al.
Page
of 10
Search research articles
Search
Showing results (91-100 of 100) with videos related to
Sort By:
Page
of 10
You have reached the last page of results.
This site can display upto 100 results.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
August 28, 2014
R47H TREM2 variant increases risk of typical early-onset Alzheimer's disease but not of prion or frontotemporal dementia
Catherine F Slattery, Jonathan A Beck, Lorna Harper, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
August 6, 2021
Comparison of clinical rating scales in genetic frontotemporal dementia within the GENFI cohort
Georgia Peakman, Lucy L Russell, Rhian S Convery, et al.
Annals of Clinical and Translational Neurology
|
September 26, 2018
Presymptomatic white matter integrity loss in familial frontotemporal dementia in the GENFI cohort: A cross-sectional diffusion tensor imaging study
Lize C Jiskoot, Martina Bocchetta, Jennifer M Nicholas, et al.
BMC Neurology
|
January 23, 2024
Updating the study protocol: Insight 46 - a longitudinal neuroscience sub-study of the MRC National Survey of Health and Development - phases 2 and 3
Heidi Murray-Smith, Suzie Barker, Frederik Barkhof, et al.
Brain Communications
|
March 27, 2023
Structural MRI predicts clinical progression in presymptomatic genetic frontotemporal dementia: findings from the GENetic Frontotemporal dementia Initiative cohort
Martina Bocchetta, Emily G Todd, Arabella Bouzigues, et al.
Lancet (London, England)
|
September 11, 2019
Effect of remote ischaemic conditioning on clinical outcomes in patients with acute myocardial infarction (CONDI-2/ERIC-PPCI): a single-blind randomised controlled trial
Derek J Hausenloy, Rajesh K Kharbanda, Ulla Kristine Møller, et al.
Lancet (London, England)
|
October 4, 2025
Effect of repurposed simvastatin on disability progression in secondary progressive multiple sclerosis (MS-STAT2): a phase 3, randomised, double-blind, placebo-controlled trial
Jeremy Chataway, Thomas Williams, James Blackstone, et al.
BMJ Open
|
September 16, 2024
Evaluating the effectiveness of simvastatin in slowing the progression of disability in secondary progressive multiple sclerosis (MS-STAT2): protocol for a multicentre, randomised controlled, double-blind, phase 3 clinical trial in the UK
James Blackstone, Thomas Williams, Jennifer M Nicholas, et al.
Health Technology Assessment (Winchester, England)
|
June 29, 2026
Evaluating the effectiveness of simvastatin in slowing the progression of disability in secondary progressive multiple sclerosis: a synopsis of MS-STAT2, a multicentre, randomised controlled, double-blind, phase 3 clinical trial
Thomas Williams, James Blackstone, Nevin John, et al.
The Lancet. Neurology
|
February 10, 2015
Presymptomatic cognitive and neuroanatomical changes in genetic frontotemporal dementia in the Genetic Frontotemporal dementia Initiative (GENFI) study: a cross-sectional analysis
Jonathan D Rohrer, Jennifer M Nicholas, David M Cash, et al.
Page
of 10